<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" id="no-js"><!-- InstanceBegin template="/Templates/ContentPage_Standard.dwt" codeOutsideHTMLIsLocked="false" -->

<head>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<!-- InstanceBeginEditable name="title-tag" -->
<title>CDC - Appendix  C - 2011 BSI Guidelines - HICPAC</title>
<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="meta-data" -->
<meta name="Keywords" 		content="BSI, catheter, central venous catheter (CVC)" />
<meta name="DC.Subject" 	content="" />
<meta name="DC.Language" 	scheme="ISO 639-2" content="eng" />
<meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7" />
<!-- InstanceEndEditable --><!-- InstanceParam name="class" type="text" value="secondTier" --><!-- InstanceParam name="localFilesPath" type="text" value="/hicpac/" --><!-- InstanceParam name="content" type="boolean" value="true" --><!-- InstanceParam name="optionSpanish" type="boolean" value="false" --><!-- InstanceParam name="optionalFeatures" type="boolean" value="false" --><!-- InstanceParam name="optionalBreadCrumbs" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalSearch" type="boolean" value="false" --><!-- InstanceParam name="OptionalLocalA-Z" type="boolean" value="false" --><!-- InstanceParam name="optionalExtra" type="boolean" value="false" --><!-- InstanceParam name="JqueryUI" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiAccordion" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiCarousel" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiDatePicker" type="boolean" value="false" --><!-- InstanceParam name="JqueryUiTabs" type="boolean" value="false" --><!-- InstanceParam name="dojoLibrary" type="boolean" value="false" -->

<meta http-equiv="content-type" content="text/html; charset=utf-8" />

<meta name="template.version" content="2.7.1.3" />
<!-- @package: TemplatePackage 'B' @version: "2.7.1.3" -->
<style type="text/css" media="screen">empty{color:#000};@import "https://hicpac//local/B/css/designview/designTime.css"/**/;</style>
<link rel="stylesheet" href="../../TemplatePackage/css/B/reset.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../TemplatePackage/css/B/newMods.css" type="text/css" media="screen" />
<link rel="stylesheet" href="../../TemplatePackage/css/B/print.css" type="text/css" media="print" />

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie6_fixes.css" />
<![endif]-->

<!--[if IE 7]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie7_fixes.css" />
<![endif]-->

<!--[if IE 8]>
<link rel="stylesheet" type="text/css" href="/TemplatePackage/css/B/ie8_fixes.css" />
<![endif]-->
<!-- /end compliance patch for microsoft browsers -->
<!-- JS below -->
<script type="text/javascript">(function(H){H.id=H.id.replace('no-','')})(document.documentElement)</script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/jquery.watermark.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/common.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/startup.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/socialMedia.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/blocks-ie.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/video.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/navScripts.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/govdelivery.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/anchor.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/syndicateThisPage.js"></script>
<script type="text/javascript" src="../../TemplatePackage/js/B/css-include.js"></script>
<script type="text/javascript" src="../../TemplatePackage/3.0/js/libs/moment/moment.min.js"></script>

<!-- compliance patch for microsoft browsers -->
<!--[if IE 6]>
<script type="text/javascript" src="/TemplatePackage/js/B/pngfix.js"></script>
<script type="text/javascript" src="/TemplatePackage/js/B/blocks-ie6.js"></script>
<![endif]-->

<!--[if lte IE 8]>
<script type="text/javascript" src="/TemplatePackage/js/B/jquery.curvycorners.js"></script>
<![endif]-->

<script type="text/javascript" src="../../TemplatePackage/js/B/cdc-gridCompatibility.js"></script>

<link rel="shortcut icon" href="../../TemplatePackage/images/home/favicon.ico" />
<link rel="home" href="../../index.html" title="Home" />

<!-- Begin Survey scripts -->
<script type="text/javascript" src="../../JScript/foresee/foresee-trigger.js"></script>
<script type="text/javascript" src="../../JScript/foresee-variables.js"></script>
<!-- End Survey scripts -->

<!-- InstanceBeginEditable name="local-css" -->
<style type="text/css" media="all">
@import "../local/B/css/local.css"/**/;
</style>
<script type="text/javascript" src="http://www.cdc.gov/news/scripts/govdelivery.js"></script>
<!--[if IE]>
<script defer language="javascript" type="text/javascript">
		var cdcLeftNav = new CDC.LeftNav("nav-primary");
		cdcLeftNav.render();
</script>
<![endif]-->
<!--[if ! IE]><!-->
<script language="javascript" type="text/javascript">
$().ready(function(){
		
		var cdcLeftNav = new CDC.LeftNav("nav-primary", location.pathname, true, true);
		cdcLeftNav.render();

});
</script>
<!--<![endif]-->

<!-- InstanceEndEditable -->
</head>
<body id="contentPageStandard" class="secondTier secondTier v270">

<div id="skipmenu">
	<a href="12-appendix-C-BSI-guidelines-2011.html#searchBox" class="skippy" title="Skip to search">Skip directly to search</a>
	<a href="12-appendix-C-BSI-guidelines-2011.html#az" class="skippy" title="Skip to A to Z list">Skip directly to A to Z list</a>
	<a href="12-appendix-C-BSI-guidelines-2011.html#nav" class="skippy" title="Skip to navigation">Skip directly to navigation</a>
	<a href="12-appendix-C-BSI-guidelines-2011.html#content-main" class="skippy" title="Skip to content">Skip directly to site content</a>
	<a href="12-appendix-C-BSI-guidelines-2011.html#content-secondary" class="skippy" title="Skip to page options">Skip directly to page options</a>
</div>
<div id="wrapper">
	<div id="wrapper-inner">
		<div id="branding">
			<span id="homeward"><a href="../../index.html" title="Return to the CDC Home Page">CDC Home</a></span>
<div id="branding-logo">
	<div id="branding-logoImage"><img src="../../TemplatePackage/images/cdcHeaderLogo.gif" width="470" height="47" alt="CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People." border="0" /><a href="../../index.html" title="CDC 24/7: Saving Lives. Protecting People.&trade;"><span>CDC 24/7: Saving Lives. Protecting People.&trade;</span></a></div>

				<div id="searchForm" class="searchResize"><a name="search"></a>
		<form id="searchCDC" method="get" action="https://search.cdc.gov/search">
			<fieldset>
				<div id="cdc-Query">
					<label for="searchBox" class="overlabel search">Search The CDC</label>
					<input id="searchBox" class="searchBox" name="query" maxlength="256" type="text" />
				</div>
				<div id="cdc-Submit">
					<!-- label for="searchButton" class="searchButton">Search Button</label -->
					<input id="searchButton" class="searchButton" src="../../TemplatePackage/images/home/search_button.gif" name="searchButton" alt="Search" type="image" />
					<input name="action" value="search" type="hidden" />
				</div>
				<input type="hidden" name="utf8" value="&#x2713;"/>
				<input type="hidden" name="affiliate" value="cdc-main"/>
			</fieldset>
		</form>
	</div>
			</div>
<noscript>
<div class="noscript"> Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: <a href="../../Other/about_cdcgov.html" title="Browser requirements for CDC.gov">About CDC.gov</a>.</div>
</noscript>
<!--<div id="emergency-alert">
<h1></h1> 
<p></p>
<a href="#"></a>
</div>-->
		</div>
		
		<div id="content">
			<div id="topic-title"><!-- InstanceBeginEditable name="topic-title" -->
			<h2><a href="../index.html">Healthcare Infection Control Practices Advisory Committee (HICPAC)</a></h2>
			<!-- InstanceEndEditable -->
			</div>
			<div id="content-inner">
				<!-- ########## BREADCRUMBS START HERE ########## -->
				<!-- InstanceBeginEditable name="breadcrumbs" -->
			<div id="breadBox">
	<ul id="breadcrumbs">
		<li style="display:none;"></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
				<div id="socialMediaContainer">
	<div class="share_container noLinking">
	 	<a class="share_button_facebook" title="Facebook" href="12-appendix-C-BSI-guidelines-2011.html#"><span id="share_facebook" class="facebookRecommend"></span></a>
	 	<a class="share_button_twitter" title="Twitter" href="12-appendix-C-BSI-guidelines-2011.html#"><span id="share_twitter" class="twitterTweet"></span></a>
		<a class="share_button noLinking" href="12-appendix-C-BSI-guidelines-2011.html#socialMediaContainer"><img src="../../TemplatePackage/images/social/sm-plus.gif" alt="Share" /><span class="shareButtonEn">Share</span><span class="shareButtonEs">Compartir</span></a>
	</div>
</div>

				<div id="content-main">
					<div class="main-inner">
						<!-- InstanceBeginEditable name="content-main" -->
                        
                        <div class="syndicate">  
    <div class="mSyndicate">  

<h1>2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections	
                </h1>
                  

                <p> Download the complete <a href="https://www.cdc.gov/hicpac/pdf/guidelines/Guidelines-Prevention-of-Intravascular-Catheter-Related-Infections-2011-final.pdf">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections [PDF - 900 KB]</a></p> 
                    
				    <h2>Appendix C. </h2>
                    
                    <div class="module rounders grey bulleted-links">
<div class="inner">
<div class="t"></div>

<h4>Summary of Recommendations
</h4>
<div class="twoColumn">
<div class="c50l">
<div class="subcl">
<ul>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#ed">Education, training and staffing</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#scs">Selection of catheters and sites</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#pcmc">Peripheral catheters and midline catheters</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#cvc">Central venous catheters</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#hhat">Hand Hygiene and Aseptic Technique</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#msbp">Maximal Sterile Barrier Precautions </a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#sp">Skin Preparation</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#csdr">Catheter site dressing regimens</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#pc">Patient Cleansing</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#aaicc">Antimicrobial/Antiseptic Impregnated Catheters and Cuffs </a></li>

<li><a href="12-appendix-C-BSI-guidelines-2011.html#sap">Systemic Antibiotic Prophylaxis</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#aao">Antibiotic/Antiseptic Ointments </a></li>
</ul>
</div>
</div>

<div class="c50r">
<div class="subcr">
<ul>

<li><a href="12-appendix-C-BSI-guidelines-2011.html#alp">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#ac">Anticoagulants</a></li>

<li><a href="12-appendix-C-BSI-guidelines-2011.html#rpmc">Replacement of Peripheral and Midline Catheters
</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#rcvc">Replacement of CVCs, Including PICCs and Hemodialysis Catheters 
</a></li>

<li><a href="12-appendix-C-BSI-guidelines-2011.html#uc">Umbilical Catheters 
</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#pac">Peripheral Arterial Catheters and Pressure Monitoring Devices for Adult and Pediatric Patients 
</a></li>

<li><a href="12-appendix-C-BSI-guidelines-2011.html#ras">Replacement of Administration Sets</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#nics">Needleless Intravascular Catheter Systems</a></li>
<li><a href="12-appendix-C-BSI-guidelines-2011.html#pi">Performance Improvement</a></li>
</ul>
</div>
</div>
</div>
</div>

<div class="b">
<div></div>
</div>
</div>

                    
                    
                    <h2 id="ed">Education, training and staffing</h2>
                    <ol>
                      <li> Educate healthcare personnel regarding the indications for intravascular catheter use, proper procedures for the insertion and maintenance of intravascular catheters, and appropriate infection control measures to prevent intravascular catheter-related infections [<a href="13-references-BSI-guidelines-2011.html#r41">41-49</a>]. Category IA                        </li>
                      <li> Periodically assess knowledge of and adherence to guidelines for all personnel involved in the insertion and maintenance of intravascular catheters [<a href="13-references-BSI-guidelines-2011.html#r41">41-49</a>]. Category IA                        </li>
                      <li> Designate only trained personnel who demonstrate competence for the insertion and maintenance of peripheral and central intravascular catheters. [<a href="13-references-BSI-guidelines-2011.html#r48">48</a>-<a href="13-references-BSI-guidelines-2011.html#r62">62</a>]. Category IA                        </li>
                      <li> Ensure appropriate nursing staff levels in ICUs Observational studies suggest that a higher proportion of &quot;pool nurses&quot; or an elevated patient–to-nurse ratio is associated with CRBSI in ICUs where nurses are managing patients with CVCs [<a href="13-references-BSI-guidelines-2011.html#r63">63-65</a>]. Category IB </li>
                </ol>
                    
                    <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                    <h2 id="scs">Selection of catheters and sites</h2>
                    <h3 id="pcmc">Peripheral catheters and midline catheters</h3>
                    <ol>
                      <li>  In adults, use an upper-extremity site for catheter insertion. Replace a catheter inserted in a lower extremity site to an upper extremity site as soon as possible. Category II                        </li>
                      <li> In pediatric patients, the upper or lower extremities or the scalp (in neonates or young infants) can be used as the catheter insertion site [<a href="13-references-BSI-guidelines-2011.html#r70">70, 71</a>]. Category II                        </li>
                      <li> Select catheters on the basis of the intended purpose and duration of use, known infectious and non-infectious complications (e.g., phlebitis and infiltration), and experience of individual catheter operators [<a href="13-references-BSI-guidelines-2011.html#r71">71-73</a>]. Category IB                        </li>
                      <li> Avoid the use of steel needles for the administration of fluids and medication that might cause tissue necrosis if extravasation occurs [<a href="13-references-BSI-guidelines-2011.html#r71">71, 72</a>]. Category IA                        </li>
                      <li>Use a midline catheter or peripherally inserted central catheter (PICC), instead of a short peripheral catheter, when the duration of IV therapy will likely exceed six days. Category II                        </li>
                      <li>Evaluate the catheter insertion site daily by palpation through the dressing to discern tenderness and by inspection if a transparent dressing is in use. Gauze and opaque dressings should not be removed if the patient has no clinical signs of infection. If the patient has local tenderness or other signs of possible CRBSI, an opaque dressing should be removed and the site inspected visually. Category II                        </li>
                      <li> Remove peripheral venous catheters if the patients develops signs of phlebitis (warmth, tenderness, erythema or palpable venous cord), infection, or a malfunctioning catheter [<a href="13-references-BSI-guidelines-2011.html#r74">74</a>]. Category IB                      </li>
                      
                </ol>
                      
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      <h3 id="cvc">Central venous catheters                      </h3>
                      <ol>
                        <li>Weigh the risks and benefits of placing a central venous device at a recommended site to reduce infectious complications against the risk for mechanical complications (e.g., pneumothorax, subclavian artery puncture, subclavian vein laceration, subclavian vein stenosis, hemothorax, thrombosis, air embolism, and catheter misplacement) [<a href="13-references-BSI-guidelines-2011.html#r13">13</a>, <a href="13-references-BSI-guidelines-2011.html#r75">75</a>-<a href="13-references-BSI-guidelines-2011.html#r90">90</a>]. Category IA                        </li>
                        <li>Avoid using the femoral vein for central venous access in adult patients [<a href="13-references-BSI-guidelines-2011.html#r75">75</a>,<a href="13-references-BSI-guidelines-2011.html#r87"> 87, 88, 91</a>]. Category 1A</li>
                        <li> Use a subclavian site, rather than a jugular or a femoral site, in adult patients to minimize infection risk for nontunneled CVC placement [<a href="13-references-BSI-guidelines-2011.html#r87">87-89</a>]. Category IB</li>
                        <li> No recommendation can be made for a preferred site of insertion to minimize infection risk for a tunneled CVC. Unresolved issue                        </li>
                        <li>Avoid the subclavian site in hemodialysis patients and patients with advanced kidney disease, to avoid subclavian vein stenosis [<a href="13-references-BSI-guidelines-2011.html#r90">90, 92-95</a>]. Category IA                        </li>
                        <li>Use a fistula or graft in patients with chronic renal failure instead of a CVC for permanent access for dialysis [<a href="13-references-BSI-guidelines-2011.html#r96">96</a>]. Category 1A                        </li>
                        <li> Use ultrasound guidance to place central venous catheters (if this technology is available) to reduce the number of cannulation attempts and mechanical complications. Ultrasound guidance should only be used by those fully trained in its technique.  [<a href="13-references-BSI-guidelines-2011.html#r97">97-101</a>]. Category 1B                        </li>
                        <li>Use a CVC with the minimum number of ports or lumens essential for the management of the patient [<a href="13-references-BSI-guidelines-2011.html#r102">102-105</a>]. Category IB                        </li>
                        <li> No recommendation can be made regarding the use of a designated lumen for parenteral nutrition. Unresolved issue                        </li>
                        <li>Promptly remove any intravascular catheter that is no longer essential [<a href="13-references-BSI-guidelines-2011.html#r106">106-109</a>]. Category IA                        </li>
                        <li> When adherence to aseptic technique cannot be ensured (i.e. catheters inserted during a medical emergency), replace the catheter as soon as possible, i.e., within 48 hours [<a href="13-references-BSI-guidelines-2011.html#r13">13</a>, <a href="13-references-BSI-guidelines-2011.html#r110">110-113</a>].  Category IB                        </li>                      
                </ol>
                          </li>
                      </ol>
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="hhat">Hand Hygiene and Aseptic Technique</h2>
                      <ol>
                        <li> Perform hand hygiene procedures, either by washing hands with conventional soap and water or with alcohol-based hand rubs (ABHR). Hand hygiene should be performed before and after palpating catheter insertion sites as well as before and after inserting, replacing, accessing, repairing, or dressing an intravascular catheter. Palpation of the insertion site should not be performed after the application of antiseptic, unless aseptic technique is maintained [<a href="13-references-BSI-guidelines-2011.html#r46">46</a>, <a href="13-references-BSI-guidelines-2011.html#r126">126-128</a>]. Category IB                          </li>
                        <li>Maintain aseptic technique for the insertion and care of intravascular catheters [<a href="13-references-BSI-guidelines-2011.html#r13">13</a>, <a href="13-references-BSI-guidelines-2011.html#r110">110, 111, 113</a>]. Category IB                          </li>
                        <li>Wear clean gloves, rather than sterile gloves, for the insertion of peripheral intravascular catheters, if the access site is not touched after the application of skin antiseptics. Category IC                          </li>
                        <li>Sterile gloves should be worn for the insertion of arterial, central, and midline catheters [<a href="13-references-BSI-guidelines-2011.html#r13">13</a>, <a href="13-references-BSI-guidelines-2011.html#r110">110, 111, 113</a>]. Category IA                          </li>
                        <li>Use new sterile gloves before handling the new catheter when guidewire exchanges are performed. Category II                          </li>
                        <li>Wear either clean or sterile gloves when changing the dressing on intravascular catheters. Category IC </li>
                      </ol>
                      
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="msbp">Maximal Sterile Barrier Precautions                        </h2>
                      <ol>
                        <li> Use maximal sterile barrier precautions, including the use of a cap, mask, sterile gown, sterile gloves, and a sterile full body drape, for the insertion of CVCs, PICCs, or guidewire exchange [<a href="13-references-BSI-guidelines-2011.html#r48">48</a>, <a href="13-references-BSI-guidelines-2011.html#r112">112, 113</a>, <a href="13-references-BSI-guidelines-2011.html#r130">130</a>]. Category IB
                          2. Use a sterile sleeve to protect pulmonary artery catheters during insertion [<a href="13-references-BSI-guidelines-2011.html#r131">131</a>]. Category IB </li>
                </ol>
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="sp">Skin Preparation</h2>
                      <ol>
                        <li> Prepare clean skin with an antiseptic (70% alcohol, tincture of iodine, an iodophor or chlorhexidine gluconate) before peripheral venous catheter insertion [<a href="13-references-BSI-guidelines-2011.html#r132">132</a>]. Category IB                          </li>
                        <li>Prepare clean skin with a &gt;0.5% chlorhexidine preparation with alcohol before central venous catheter and peripheral arterial catheter insertion and during dressing changes. If there is a contraindication to chlorhexidine, tincture of iodine, an iodophor, or 70% alcohol can be used as alternatives [<a href="13-references-BSI-guidelines-2011.html#r133">133, 134</a>]. Category IA                          </li>
                        <li> No comparison has been made between using chlorhexidine preparations with alcohol and povidone-iodine in alcohol to prepare clean skin. Unresolved issue.                          </li>
                        <li>No recommendation can be made for the safety or efficacy of chlorhexidine in infants aged &lt;2 months. Unresolved issue                          </li>
                        <li> Antiseptics should be allowed to dry according to the manufacturer’s recommendation prior to placing the catheter [<a href="13-references-BSI-guidelines-2011.html#r133">133, 134</a>]. Category IB </li>
                </ol>
                      
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="csdr">Catheter site dressing regimens</h2>
                      <ol>
                        <li>  Use either sterile gauze or sterile, transparent, semi-permeable dressing to cover the catheter site [<a href="13-references-BSI-guidelines-2011.html#r139">139-142</a>]. Category IA                          </li>
                        <li>If the patient is diaphoretic or if the site is bleeding or oozing, use gauze dressing until this is resolved [<a href="13-references-BSI-guidelines-2011.html#r139">139-142</a>]. Category II                          </li>
                        <li> Replace catheter site dressing if the dressing becomes damp, loosened, or visibly soiled [<a href="13-references-BSI-guidelines-2011.html#r139">139, 140</a>]. Category IB                          </li>
                        <li>Do not use topical antibiotic ointment or creams on insertion sites, except for dialysis catheters, because of their potential to promote fungal infections and antimicrobial resistance [<a href="13-references-BSI-guidelines-2011.html#r143">143, 144</a>]. Category IB                          </li>
                        <li> Do not submerge the catheter or catheter site in water. Showering should be permitted if precautions can be taken to reduce the likelihood of introducing organisms into the catheter (e.g., if the catheter and connecting device are protected with an impermeable cover during the shower) [<a href="13-references-BSI-guidelines-2011.html#r145">145-147</a>]. Category IB                          </li>
                        <li> Replace dressings used on short-term CVC sites every 2 days for gauze dressings. Category II                          </li>
                        <li> Replace dressings used on short-term CVC sites  at least every 7 days for transparent dressings, except in those pediatric patients in which the risk for dislodging the catheter may outweigh the benefit of changing the dressing [<a href="13-references-BSI-guidelines-2011.html#r142">142, 148</a>]. Category IB                          </li>
                        <li>Replace transparent dressings used on tunneled or implanted CVC sites no more than once per week (unless the dressing is soiled or loose), until the insertion site has healed. Category II                          </li>
                        <li>No recommendation can be made regarding the necessity for any dressing on well-healed exit sites of long-term cuffed and tunneled CVCs. Unresolved issue                          </li>
                        <li>Ensure that catheter site care is compatible with the catheter material [149, 150]. Category IB                          </li>
                        <li> Use a sterile sleeve for all pulmonary artery catheters [<a href="13-references-BSI-guidelines-2011.html#r131">131</a>]. Category IB                          </li>
                        <li>Use a chlorhexidine-impregnated sponge dressing for temporary short-term catheters in patients older than 2 months of age if the CLABSI rate is not decreasing despite adherence to basic prevention measures, including education and training, appropriate use of chlorhexidine for skin antisepsis, and MSB [<a href="13-references-BSI-guidelines-2011.html#r148">148, 151-153</a>]. Category 1B                          </li>
                        <li> No recommendation is made for other types of chlorhexidine dressings. Unresolved issue                          </li>
                        <li>Monitor the catheter sites visually when changing the dressing or by palpation through an intact dressing on a regular basis, depending on the clinical situation of the individual patient. If patients have tenderness at the insertion site, fever without obvious source, or other manifestations suggesting local or bloodstream infection, the dressing should be removed to allow thorough examination of the site [<a href="13-references-BSI-guidelines-2011.html#r156">154-156</a>]. Category IB                          </li>
                        <li>Encourage patients to report any changes in their catheter site or any new discomfort to their provider. Category II </li>
                      </ol>
                      
                      <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="pc">Patient Cleansing                      </h2>
                      <p>Use a 2% chlorhexidine wash for daily skin cleansing to reduce CRBSI [160-162]. Category II
                        Catheter Securement Devices 
                        Use a sutureless securement device to reduce the risk of infection for intravascular catheters [<a href="13-references-BSI-guidelines-2011.html#r163">163</a>]. Category II                      </p>
                        
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                        
                      <h2 id="aaicc">Antimicrobial/Antiseptic Impregnated Catheters and Cuffs                      </h2>
                      <p>Use a chlorhexidine/silver sulfadiazine or minocycline/rifampin -impregnated CVC in patients whose catheter is expected to remain in place &gt;5 days if, after successful implementation of a comprehensive strategy to reduce rates of CLABSI, the CLABSI rate is not decreasing. The comprehensive strategy should include at least the following three components: educating persons who insert and maintain catheters, use of maximal sterile barrier precautions, and a &gt;0.5% chlorhexidine preparation with alcohol for skin antisepsis during CVC insertion [<a href="13-references-BSI-guidelines-2011.html#r164">164-171</a>]. Category IA                      </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="sap">Systemic Antibiotic Prophylaxis                        </h2>
                      <p>Do not administer systemic antimicrobial prophylaxis routinely before insertion or during use of an intravascular catheter to prevent catheter colonization or CRBSI [<a href="13-references-BSI-guidelines-2011.html#r189">189</a>].   Category IB                        </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      <h2 id="aao">Antibiotic/Antiseptic Ointments                        </h2>
                      <p>Use povidone iodine antiseptic ointment or bacitracin/gramicidin/polymyxin B  ointment at the hemodialysis catheter exit site after catheter insertion and at the end of each dialysis session only if this ointment does not interact with the material of the hemodialysis catheter per manufacturer's recommendation [<a href="13-references-BSI-guidelines-2011.html#r96">96</a>, <a href="13-references-BSI-guidelines-2011.html#r132">132</a>, <a href="13-references-BSI-guidelines-2011.html#r195">195-198</a>]. Category IB                        </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      <h2 id="alp">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis                        </h2>
                      <p>Use prophylactic antimicrobial lock solution in patients with long term catheters who have a history of multiple CRBSI despite optimal maximal adherence to aseptic technique [<a href="13-references-BSI-guidelines-2011.html#r211">211-229</a>]. Category II                        </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      <h2 id="ac">Anticoagulants                        </h2>
                      <p>Do not routinely use anticoagulant therapy to reduce the risk of catheter-related infection in general patient populations [<a href="13-references-BSI-guidelines-2011.html#r235">235</a>]. Category II </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      
                      
                      <h2 id="rpmc">Replacement of Peripheral and Midline Catheters</h2>
                      <ol>
                        <li>  There is no need to replace peripheral catheters more frequently than every 72-96 hours to reduce risk of infection and phlebitis in adults [<a href="13-references-BSI-guidelines-2011.html#r74">74</a>, <a href="13-references-BSI-guidelines-2011.html#r256">256, 257</a>]. Category 1B                          </li>
                        <li>No recommendation is made regarding replacement of peripheral catheters in adults only when clinically indicated [<a href="13-references-BSI-guidelines-2011.html#r258">258-260</a>]. Unresolved issue                          </li>
                        <li>Replace peripheral catheters in children only when clinically indicated [<a href="13-references-BSI-guidelines-2011.html#r70">70, 71</a>].  Category 1B                          </li>
                        <li>Replace midline catheters only when there is a specific indication. Category II </li>
                </ol>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                      <h2 id="rcvc">Replacement of CVCs, Including PICCs and Hemodialysis Catheters                      </h2>
                      <ol>
                        <li>Do not routinely replace CVCs, PICCs, hemodialysis catheters, or pulmonary artery catheters to prevent catheter-related infections. Category IB                          </li>
                        <li> Do not remove CVCs or PICCs on the basis of fever alone. Use clinical judgment regarding the appropriateness of removing the catheter if infection is evidenced elsewhere or if a noninfectious cause of fever is suspected. Category II</li>
                        <li> Do not use guidewire exchanges routinely for non-tunneled catheters to prevent infection. Category IB                          </li>
                        <li> Do not use guidewire exchanges to replace a non-tunneled catheter suspected of infection. Category IB </li>
                        <li>Use a guidewire exchange to replace a malfunctioning non-tunneled catheter if no evidence of infection is present. Category IB</li>
                        <li> Use new sterile gloves before handling the new catheter when guidewire exchanges are performed. Category II </li>
                      </ol>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                        
                      <h2 id="uc">Umbilical Catheters                      </h2>
                      <ol>
                        <li>Remove and do not replace umbilical artery catheters if any signs of CRBSI, vascular insufficiency in the lower extremeties, or thrombosis are present [<a href="13-references-BSI-guidelines-2011.html#r281">281</a>]. Category II</li>
                        <li> Remove and do not replace umbilical venous catheters if any signs of CRBSI or thrombosis are present [<a href="13-references-BSI-guidelines-2011.html#r281">281</a>]. Category II                          </li>
                        <li> No recommendation can be made regarding attempts to salvage an umbilical catheter by administering antibiotic treatment through the catheter. Unresolved issue                          </li>
                        <li> Cleanse the umbilical insertion site with an antiseptic before catheter insertion. Avoid tincture of iodine because of the potential effect on the neonatal thyroid. Other iodine-containing products (e.g., povidone iodine) can be used [<a href="13-references-BSI-guidelines-2011.html#r282">282-286</a>]. Category IB                          </li>
                        <li> Do not use topical antibiotic ointment or creams on umbilical catheter insertion sites because of the potential to promote fungal infections and antimicrobial resistance [<a href="13-references-BSI-guidelines-2011.html#r143">143, 144</a>]. Category IA                          </li>
                        <li> Add low-doses of heparin (0.25-1.0 U/ml) to the fluid infused through umbilical arterial catheters [<a href="13-references-BSI-guidelines-2011.html#r287">287-289</a>]. Category IB</li>
                        <li> Remove umbilical catheters as soon as possible when no longer needed or when any sign of vascular insufficiency to the lower extremities is observed. Optimally, umbilical artery catheters should not be left in place &gt;5 days [<a href="13-references-BSI-guidelines-2011.html#r281">281, 290</a>]. Category II</li>
                        <li> Umbilical venous catheters should be removed as soon as possible when no longer needed, but can be used up to 14 days if managed aseptically [<a href="13-references-BSI-guidelines-2011.html#r291">291, 292</a>]. Category II                          </li>
                        <li> An umbilical catheter may be replaced if it is malfunctioning, and there is no other indication for catheter removal, and the total duration of catheterization has not exceeded 5 days for an umbilical artery catheter or 14 days for an umbilical vein catheter. Category II </li>
                      </ol>
                      
                        <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                        
                      <h2 id="pac">Peripheral Arterial Catheters and Pressure Monitoring Devices for Adult and Pediatric Patients                      </h2>
                      <ol>
                        <li> In adults, use of the radial, brachial or dorsalis pedis sites is preferred over the femoral or axillary sites of insertion to reduce the risk of infection [<a href="13-references-BSI-guidelines-2011.html#r83">83, 84</a>, <a href="13-references-BSI-guidelines-2011.html#r295">295, 296</a>]. Category IB                          </li>
                        <li> In children, the brachial site should not be used. The radial, dorsalis pedis, and posterior tibial sites are preferred over the femoral or axillary sites of insertion [<a href="13-references-BSI-guidelines-2011.html#r83">83</a>]. Category II                          </li>
                        <li> A minimum of a cap, mask, sterile gloves and a small sterile fenestrated drape should be used during peripheral arterial catheter insertion [<a href="13-references-BSI-guidelines-2011.html#r84">84</a>, <a href="13-references-BSI-guidelines-2011.html#r296">296, 297</a>]. Category IB</li>
                        <li> During axillary or femoral artery catheter insertion, maximal sterile barriers precautions should be used. Category II</li>
                        <li>Replace arterial catheters only when there is a clinical indication. Category II                          </li>
                        <li> Remove the arterial catheter as soon as it is no longer needed. Category II                          </li>
                        <li>Use disposable, rather than reusable, transducer assemblies when possible [<a href="13-references-BSI-guidelines-2011.html#r298">298-302</a>]. Category IB                          </li>
                        <li> Do not routinely replace arterial catheters to prevent catheter-related infections [<a href="13-references-BSI-guidelines-2011.html#r265">265</a>, <a href="13-references-BSI-guidelines-2011.html#r279">279</a>, <a href="13-references-BSI-guidelines-2011.html#r303">303, 304</a>]. Category II                          </li>
                        <li>Replace disposable or reusable transducers at 96-hour intervals. Replace other components of the system (including the tubing, continuous-flush device, and flush solution) at the time the transducer is replaced [<a href="13-references-BSI-guidelines-2011.html#r13">13</a>, <a href="13-references-BSI-guidelines-2011.html#r299">299</a>]. Category IB                          </li>
                        <li>Keep all components of the pressure monitoring system (including calibration devices and flush solution) sterile [<a href="13-references-BSI-guidelines-2011.html#r298">298, 305-307</a>]. Category IA                          </li>
                        <li> Minimize the number of manipulations of and entries into the pressure monitoring system. Use a closed flush system (i.e., continuous flush), rather than an open system (i.e., one that requires a syringe and stopcock), to maintain the patency of the pressure monitoring catheters [<a href="13-references-BSI-guidelines-2011.html#r301">301, 308</a>]. Category II                          </li>
                        <li> When the pressure monitoring system is accessed through a diaphragm, rather than a stopcock, scrub the diaphragm with an appropriate antiseptic before accessing the system [<a href="13-references-BSI-guidelines-2011.html#r301">301</a>]. Category IA                          </li>
                        <li> Do not administer dextrose-containing solutions or parenteral nutrition fluids through the pressure monitoring circuit [<a href="13-references-BSI-guidelines-2011.html#r301">301</a>, <a href="13-references-BSI-guidelines-2011.html#r309">309, 310</a>]. Category IA                          </li>
                        <li> Sterilize reusable transducers according to the manufacturers' instructions if the use of disposable transducers is not feasible [<a href="13-references-BSI-guidelines-2011.html#r301">301</a>, <a href="13-references-BSI-guidelines-2011.html#r309">309-312</a>]. Category IA </li>
                </ol>
                      
                        <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                      <h2 id="ras">Replacement of Administration Sets                      </h2>
                      <ol>
                        <li> In patients not receiving blood, blood products or fat emulsions, replace administration sets that are continuously used, including secondary sets and add-on devices, no more frequently than at 96-hour intervals, [<a href="13-references-BSI-guidelines-2011.html#r316">316</a>] but at least every 7 days [<a href="13-references-BSI-guidelines-2011.html#r317">317-320</a>]. Category IA                          </li>
                        <li> No recommendation can be made regarding the frequency for replacing intermittently used administration sets.Unresolved issue                          </li>
                        <li>No recommendation can be made regarding the frequency for replacing needles to access implantable ports. Unresolved issue                          </li>
                        <li> Replace tubing used to administer blood, blood products, or fat emulsions (those combined with amino acids and glucose in a 3-in-1 admixture or infused separately) within 24 hours of initiating the infusion [<a href="13-references-BSI-guidelines-2011.html#r321">321-324</a>]. Category IB                          </li>
                        <li>Replace tubing used to administer propofol infusions every 6 or 12 hours, when the vial is changed, per the manufacturer's recommendation (FDA website Medwatch) [<a href="13-references-BSI-guidelines-2011.html#r325">325</a>]. Category IA                          </li>
                        <li> No recommendation can be made regarding the length of time a needle used to access implanted ports can remain in place. Unresolved issue </li>
                      </ol>
                      
                        <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      <h2 id="nics">Needleless Intravascular Catheter Systems                      </h2>
                      <ol>
                        <li> Change the needleless components at least as frequently as the administration set. There is no benefit to changing these more frequently than every 72 hours. [<a href="13-references-BSI-guidelines-2011.html#r76">76</a>, <a href="13-references-BSI-guidelines-2011.html#r333">333-339</a>]. Category II                          </li>
                        <li> Change needleless connectors no more frequently than every 72 hours or according to manufacturers' recommendations for the purpose of reducing infection rates [<a href="13-references-BSI-guidelines-2011.html#r333">333, 335</a>, <a href="13-references-BSI-guidelines-2011.html#r338">338, 339</a>]. Category II                          </li>
                        <li> Ensure that all components of the system are compatible to minimize leaks and breaks in the system [<a href="13-references-BSI-guidelines-2011.html#r340">340</a>]. Category II</li>
                        <li> Minimize contamination risk by scrubbing the access port with an appropriate antiseptic (chlorhexidine, povidone iodine, an iodophor, or 70% alcohol) and accessing the port only with sterile devices [<a href="13-references-BSI-guidelines-2011.html#r335">335, 338, 340-342</a>]. Category IA                          </li>
                        <li>Use a needleless system to access IV tubing. Category IC                          </li>
                        <li>When needleless systems are used, a split septum valve may be preferred over some mechanical valves due to increased risk of infection with the mechanical valves [<a href="13-references-BSI-guidelines-2011.html#r343">343-346</a>]. Category II </li>
                </ol>
                      
                        <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                      <h2 id="pi">Performance Improvement                      </h2>
                      <p>Use hospital-specific or collaborative-based performance improvement initiatives in which multifaceted strategies are "bundled" together to improve compliance with evidence-based recommended practices [<a href="13-references-BSI-guidelines-2011.html#r49">49</a>, <a href="13-references-BSI-guidelines-2011.html#r106">106, 107</a>, <a href="13-references-BSI-guidelines-2011.html#r355">355, 357-360</a>]. Category IB                      </p>
                      
                <p class="topOPage"><a href="12-appendix-C-BSI-guidelines-2011.html#">Top of Page</a></p> 
                        
                        <div class="module rounders grey multiPage-horiz" id="tableOfContent">
<div class="inner">
<div class="t"></div>

<div class="hd">
<h4><span><a href="11-appendix-B-BSI-guidelines-2011.html">Previous Page</a></span>
<span class="nextLink"><a href="13-references-BSI-guidelines-2011.html">Next Page</a></span></h4>
</div>

<div class="bd"><span><a href="toc-BSI-guidelines-2011.html">Table of Contents</a></span></div>
</div>

<div class="b">
<div></div>
</div>
</div>

                        
    </div>
                        </div>
                        
          <!-- InstanceEndEditable -->
					<!-- /end .main-inner --></div>
					
					<div id="linkPolicy">&nbsp;</div>
				<!-- /end #content-main--></div>
				
			<!-- /end #content-inner --></div>
			
			<!-- ########## RIGHT COLUMN STARTS HERE ########## -->
			<div id="content-secondary">
				<div class="pageOptions">
					<div class="pageOptions-inner">
						<ul id="services" class="services">
							<li class="print"><a href="javascript:window.print();" title="Print page.">Print page</a></li>
						</ul>
						<!-- InstanceBeginEditable name="local-options" -->
                        
                        
                    
                    

					
					<!-- InstanceEndEditable --><!-- InstanceBeginEditable name="languages" -->				<!-- InstanceEndEditable -->
					</div>
				</div>
				
				
				<!-- InstanceBeginEditable name="gov-delivery" -->
			  
			<!-- InstanceEndEditable -->
				<!-- InstanceBeginEditable name="contact-info" -->
			<div id="contact-info">
	<h5>Contact Us:</h5>
	<ul class="noBullet">
		<li class="mail">Centers for Disease Control and Prevention<br />
		1600 Clifton Rd<br />
		Atlanta, GA 30333</li>
		<li class="phone">800-CDC-INFO<br />
		(800-232-4636)<br />
		TTY: (888) 232-6348</li>
		<li><a href="../../cdc-info/requestform.html">Contact CDC&ndash;INFO</a></li>
	</ul>
</div>
			<!-- InstanceEndEditable -->
			<!-- /end #content-secondary --></div>
			
			<!-- ########## LEFT NAVIGATION STARTS HERE ########## -->
			<div id="nav-container"><!-- InstanceBeginEditable name="left-nav-include" --> 
			<div id="nav">
  <h3><a href="../index.html">HICPAC</a></h3>
	<ul id="nav-primary">
    <li><a href="../about.html">About HICPAC</a></li>
    <li><a href="../roster.html">Member Roster</a></li>
    <li><a href="../charter.html">Charter</a> </li>
    <li><a href="../eCalendar.html">Event Calendar</a>
      <!--ul>
        <li><a href="/hicpac/agenda.html">Meeting Agenda</a></li>  
      </ul-->
    </li>
    <li><a href="../guidelineMethod/guidelineMethod.html">Methodology Guideline</a>
      <ul>
        <li><a href="../guidelineMethod/001_methods_background.html">Background</a></li>
        <li><a href="../guidelineMethod/002_methods_emergingNeeds.html">Strengthening HICPAC Guidelines to Address Emerging Needs</a></li>
        <li><a href="../guidelineMethod/003_methods_Organiz2AccomplishGoals.html">Organizing to Accomplish Our Goals</a> </li>
        <li><a href="../guidelineMethod/004_methods_guidelineDevelopment.html">Methods in Guideline Development</a></li>
        <li><a href="../guidelineMethod/005_methods_challengesOpportunities.html">Looking to Future Challenges and Opportunities</a></li>
        <li><a href="../guidelineMethod/007_methods_References.html">References</a></li>
        <li><a href="../guidelineMethod/008_methods_tables.html">Tables</a></li>
        <li><a href="../guidelineMethod/011_methods_figures.html">Figures</a></li>
      </ul>
    </li>
	<!--li><a href="/hicpac/projects_in_progress.html">Projects in Progress</a></li-->
	<li><a href="../pubs.html">Publications</a>
			<ul>
			  <li><a href="BSI-guidelines-2011.html">2011 Guidelines for the Prevention of Intravascular Catheter-Related Infections</a>
		        <ul>
		          <li><a href="toc-BSI-guidelines-2011.html">Table of Contents</a></li>
		          <li><a href="01-BSI-guidelines-2011.html">Notice to Readers</a> </li>
		          <li><a href="02-bsi-summary-of-recommendations-2011.html">Summary Of Recommendations</a> </li>
		          <li><a href="03-bsi-summary-of-recommendations-2011.html">Patient Cleansing 
		            </a></li>
		          <li><a href="04-bsi-background-info-2011.html">Background Information</a></li>
		          <li><a href="05-bsi-background-info-2011.html">Maximal Sterile Barrier Precautions 
		            </a></li>
		          <li><a href="06-bsi-background-info-2011.html">Antibiotic Lock Prophylaxis, Antimicrobial Catheter Flush and Catheter Lock Prophylaxis 
		            </a></li>
		          <li><a href="07-bsi-background-info-2011.htmles-2011.html">Replacement of Administration Sets</a></li>
		          <li><a href="bsi-table-1-2011.html">Table 1. Catheters used for venous and arterial access</a></li>
		          <li><a href="13-references-BSI-guidelines-2011.html">References</a></li>
		          <li><a href="11-appendix-B-BSI-guidelines-2011.html">Appendix B. Disclosure of financial interests or relationships</a></li>
		          <li><a href="12-appendix-C-BSI-guidelines-2011.html">Appendix C. Summary of Recommendations</a></li>
	            </ul>
			  </li>
		      <li><a href="../norovirus/002_norovirus-toc.html">2011 Norovirus Guidelines
		        </a>
		        <ul>
		          <li><a href="../norovirus/003_norovirus-abbreviations.html">Abbreviations</a></li>
					   
					   <li><a href="../norovirus/001_norovirus.html">Acknowledgement</a></li>
					   <li><a href="../norovirus/004_norovirus-exec-summary.html">Executive Summary</a></li>
					   <li><a href="../norovirus/005_norovirus-summaryOrecs.html">Summary of Recommendations</a></li>
					   <li><a href="../norovirus/006_norovirus-implement-audit.html">Implementation and Audit</a> </li>
					   <li> <a href="../norovirus/007_norovirus-recs-further-research.html">Recommendations for Further Research					     </a></li>
					   <li><a href="../norovirus/008_norovirus-background.html">Background					     </a></li>
					   <li><a href="../norovirus/009_norovirus-scope.html">Scope and Purpose</a> </li>
					   <li><a href="../norovirus/010_norovirus-methods.html">Methods</a> </li>
					   <li><a href="../norovirus/011_norovirus-evidence-review.html">Evidence Review Question 1</a>				       </li>
                       <li><a href="../norovirus/012_norovirus-evidence-q2.html">Question 2</a></li>
                       <li><a href="../norovirus/013_norovirus-evidence-q3.html">Question 3</a></li>
                  <li><a href="../norovirus/norovirus-appendix-1.html">Appendix 1</a></li>
                       <li><a href="../norovirus/norovirus-appendix-1b.html">Appendix 1B</a> </li>
                       <li><a href="../norovirus/tables/evidence-Table1.html">Evidence, Grade &amp; Study Quality Assessment Tables</a></li>
                  <li><a href="../norovirus/norovirus-appendix-3.html">Appendix 3</a></li>
                       <li><a href="../norovirus/norovirus-appendix-4.html">Appendix 4</a></li>
                       <li><a href="../norovirus/norovirus-references.html">References</a></li>
		        </ul>
		      </li>
	          <li><a href="../Disinfection_Sterilization/acknowledg.html">2008 Disinfection &amp; Sterilization Guideline</a>               
	            <ul>
	              <li><a href="../Disinfection_Sterilization/toc.html">Table of Contents</a></li>
	              <li><a href="../Disinfection_Sterilization/1_sumIntroMethTerms.html">Executive Summary</a> </li>
	              <li><a href="../Disinfection_Sterilization/2_approach.html">Approach to Disinfection and Sterilization</a> 
	                  <ul>
	                    <li><a href="../Disinfection_Sterilization/3_0disinfectEquipment.html">Disinfection of Healthcare Equipment</a></li>
                        <li><a href="../Disinfection_Sterilization/3_1deLaparoArthro.html">Laparoscopes and Arthroscopes</a> </li>
                        <li><a href="../Disinfection_Sterilization/3_2contaminatedDevices.html">Disinfection of HBV, HCV, HIV or TB-Contaminated Devices</a></li>
                        <li><a href="../Disinfection_Sterilization/3_3inactivBioAgents.html">Inactivation of Bioterrorist Agents</a></li>
                        <li><a href="../Disinfection_Sterilization/3_4surfaceDisinfection.html">Surface Disinfection</a></li>
                    </ul>
	              </li>
                  <li><a href="../Disinfection_Sterilization/4_0efficacyDS.html">Factors Affecting The Efficacy Of Disinfection And Sterilization</a></li>
                  <li><a href="../Disinfection_Sterilization/5_0cleaning.html">Cleaning</a></li>
                  <li><a href="../Disinfection_Sterilization/6_0disinfection.html">Disinfection</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/7_0formaldehyde.html">Formaldehyde</a></li>
                      <li><a href="../Disinfection_Sterilization/8_0Iodophors.html">Iodophors</a></li>
                      <li><a href="../Disinfection_Sterilization/9_0PceticAcidHydroPoxide.html">Peracetic Acid and Hydrogen Peroxide</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/10_0MiscAgents.html">Miscellaneous Inactivating Agents</a></li>
                  <li><a href="../Disinfection_Sterilization/11_0regulatory_Framework.html">Regulatory Framework for Disinfectants and Sterilants</a></li>
                  <li><a href="../Disinfection_Sterilization/13_0Sterilization.html">Sterilization</a>
                      <ul>
	                      
                        <li><a href="../Disinfection_Sterilization/13_02sterilization.html">Low-Temperature Sterilization Technologies</a></li>
		                          
                        <li><a href="../Disinfection_Sterilization/13_06PeraceticAcidSterilization.html">Peracetic Acid Sterilization</a></li>
		                         
                        <li><a href="../Disinfection_Sterilization/13_10otherSterilizationMethods.html">Other Sterilization Methods</a></li>
                        <li><a href="../Disinfection_Sterilization/13_11sterilizingPractices.html">Sterilizing Practices</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/14_00ReuseMedicalDevices.html">Reuse of Single-Use Medical Devices</a></li>
                  <li><a href="../Disinfection_Sterilization/17_00Recommendations.html">Recommendations for Disinfection and Sterilization in Health-Care Facilities</a></li>
                  <li><a href="../Disinfection_Sterilization/18_00PerformanceIndicators.html">Performance Indicators</a></li>
                  <li><a href="../Disinfection_Sterilization/19_00glossary.html">Glossary</a></li>
                  <li><a href="../Disinfection_Sterilization/table_1.html">Tables &amp; Figure</a>
                    <ul>
                      <li><a href="../Disinfection_Sterilization/table_2.html">Table 2, 3</a></li>
                      <li><a href="../Disinfection_Sterilization/fig_1.html">Figure 1</a></li>
                      <li><a href="../Disinfection_Sterilization/table_4.html">Table 4</a></li>
                      <li><a href="../Disinfection_Sterilization/table_5.html">Table 5</a></li>
                      <li><a href="../Disinfection_Sterilization/table_6.html">Table 6</a></li>
                      <li><a href="../Disinfection_Sterilization/table_7.html">Table 7, 8, 9</a></li>
                      <li><a href="../Disinfection_Sterilization/table_10.html">Table 10, 11, 12</a></li>
                    </ul>
                  </li>
                  <li><a href="../Disinfection_Sterilization/20_00reference.html">References</a></li>
                </ul>
              </li>
	          <li><a href="../2007IP/2007isolationPrecautions.html">Guideline for Isolation Precautions 2007</a>
				  <ul>
                        <li><a href="../2007IP/2007ip_ExecSummary.html">Executive Summary</a></li>
                        <li> <a href="../2007IP/2007ip_part1.html">Part I: Review of Scientific Data Regarding Transmission of Infectious Agents in Healthcare Settings</a></li>
                        <li><a href="../2007IP/2007ip_part2.html">Part II: Fundamental elements needed to prevent transmission of infectious agents in healthcare settings</a></li>
                        <li><a href="../2007IP/2007ip_part3.html">Part III: Precautions to Prevent Transmission of Infectious Agents</a></li>
                        <li><a href="../2007IP/2007ip_part4.html">Part IV: Recommendations</a></li>
                        <li><a href="../2007IP/2007ip_appendA.html">Appendix A</a></li>
                        <li><a href="../2007IP/2007ip_tables.html">Tables 1 - 5</a>
                          <ul>
                            <li><a href="../2007IP/2007ip_table2.html">Table 2</a></li>
                            <li><a href="../2007IP/2007ip_table3.html">Table 3</a></li>
                            <li><a href="../2007IP/2007ip_table4.html">Table 4</a></li>
                            <li><a href="../2007IP/2007ip_table5.html">Table 5</a></li>
                          </ul>
                        </li>
                        <li><a href="../2007IP/2007ip_fig.html">Figure. Example of Safe Donning and Removal of PPE</a></li>
                        <li><a href="../2007IP/2007ip_glossary.html">Glossary</a></li>
                        <li><a href="../2007IP/2007ip_reference.html">References</a></li>
                </ul>
			  </li>
			    
	            <li><a href="../cauti/001_cauti.html">2009 CAUTI Guideline</a>
	              <ul>
	                <li><a href="../cauti/002_cauti_toc.html">Table of Contents</a>
	                  <!--<ul><li><a href="/hicpac/Disinfection_Sterilization/1_sumIntroMethTerms-levi.html">test</a></li></ul>-->
                    </li>
                      <li><a href="../cauti/02_cauti2009_abbrev.html">Abbreviations</a></li>
                      <li><a href="../cauti/003_cauti2009_execSum.html">I. Executive Summary</a></li>
                      <li><a href="../cauti/002_cauti_sumORecom.html">II. Summary of Recommendations</a></li>
                      <li><a href="../cauti/003_ImplementAudit.html">III. Implementation and Audit</a></li>
                      <li><a href="../cauti/004_furtherResearch.html">IV. Recommendations for Further Research</a></li>
                      <li><a href="../cauti/005_background.html">V. Background</a></li>
                      <li><a href="../cauti/006_scopePurpose.html">VI. Scope and Purpose</a></li>
                      <li><a href="../cauti/007_methods.html">VII. Methods</a></li>
                      <li><a href="../cauti/008_evidenceReview.html">VIII. Evidence Review</a></li>
                      <li><a href="../cauti/009_cauti2009_References.html">References</a></li>
                      <li><a href="../cauti/010_cauti2009_figs.html">Figures</a></li>
		          </ul>
              </li>
              
              <li><a href="../CAUTI_fastFacts.html">CAUTI Guideline Fast Facts</a></li>
              <li><a href="../uti_saint_video.html">Podcast: Dr. Sanjay Saint discusses CAUTIs</a></li>
              <li><a href="../mdro/mdro_0.html">Management of MDRO's in Healthcare Settings</a>
	          <ul>
	            <li><a href="../mdro/mdro_toc.html">Table of Contents</a></li>
	            <li><a href="../mdro/mdro_1.html">Introduction</a></li>
	            <li><a href="../mdro/mdro_2.html">Background</a></li>
	            <li><a href="../mdro/mdro_3.html">Epidemiology of MDROs</a></li>
	            <li><a href="../mdro/mdro_4.html">MDRO Prevention and Control</a></li>
	            <li><a href="../mdro/mdro_4_1.html">Discussion</a></li>
	            <li><a href="../mdro/mdro_5.html">Prevention of transmission of Multidrug Resistant Organisms </a></li>
	            <li><a href="../mdro/mdro_table1.html">Tables 1-2</a></li>
	            <li><a href="../mdro/mdro_table3.html">Table 3</a> </li>
	            <li><a href="../mdro/mdro_glossary.html">Glossary - Multidrug-Resistant Organisms</a></li>
	            <li><a href="../mdro/mdro_reference.html">References</a></li>
              </ul>
	        </li>
	        <li><a href="../pubReportGuide/publicReportingHAI.html">Guidance on Public Reporting of HAIs 2003</a>
			      <ul>
			        <li><a href="../pubReportGuide/prg_tbl1.html">Table 1</a></li>
		            <li><a href="../pubReportGuide/prg_tbl2.html">Table 2</a></li>
                    <li><a href="../pubReportGuide/prHAI_reference.html">Reference</a></li>
	              </ul>
		      </li>
            <li><a href="../SSI/001_SSI.html">Guideline for Prevention of Surgical Site Infection, 1999 </a>
              <ul>
                <li><a href="../SSI/toc_SSI.html"> Table of contents</a></li>
                
                <li><a href="../SSI/002_SSI.html">Surgical Site Infection (SSI): An Overview</a></li>
                <li><a href="../SSI/003_SSI.html">Microbiology</a></li>
                <li><a href="../SSI/004_SSI.html"> Operative characteristics: Preoperative issues                                 </a></li>
                <li><a href="../SSI/005_SSI.html">Operative characteristics: Intraoperative issues 
                                 </a></li>
                <li><a href="../SSI/006_SSI.html">SSI Surveillance </a></li>
                <li><a href="../SSI/007_SSI.html">Recommendations for Prevention of SSI</a></li>
                <li><a href="../SSI/ref-SSI.html">References </a></li>
                <li><a href="../SSI/figure-SSI.html">Figure</a></li>
                <li><a href="../SSI/table1-SSI.html">Table 1</a></li>
                <li><a href="../SSI/table2-SSI.html">Table 2</a></li>
                <li><a href="../SSI/table3-SSI.html">Table 3</a></li>
                <li><a href="../SSI/table4-SSI.html">Table 4</a></li>
                <li><a href="../SSI/table5-SSI.html">Table 5</a></li>
                <li><a href="../SSI/table6-SSI.html">Table 6</a></li>
                <li><a href="../SSI/table7-8-9-10-SSI.html">Table 7-8-9-10</a></li>
              </ul>
            </li>
            <li><a href="../Pubs/Antibiotic-Stewardship-Statement.html">Antibiotic Stewardship Statement for Antibiotic Guidelines, 2016</a></li>
      </ul>
	  </li>
       
	<li><a href="../presentations.html">Proceedings &amp; Presentations</a>
	  <!--ul>
	    <li><a href="/hicpac/transcript-07-23.html">July 09 - Interim Guidance for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
        <li><a href="/hicpac/h1n12009.html">Summary of Recommendations for Care of Patients with Confirmed /Suspected 2009 H1N1</a></li>
	  </ul-->
	</li>
   
    <!--li><a href="/hicpac/registration.html">HICPAC Online Registration</a></li-->
    <li><a href="../contact.html">Contact HICPAC</a></li>
  </ul>
</div>
<div class="bottom"></div>

              <p> 
              </p>
			  
             
				<!-- InstanceEndEditable -->
			</div>
			
		<!-- /end #content --></div>
		
		<div class="preFoot">
			<div id="plugin-legend">
			<h3>File Formats Help:</h3>
			<ul>
				<li class="plugin-pdf"><a href="../../Other/plugins/index.html#pdf"><img src="../../TemplatePackage/images/icon_pdf.gif" alt="Adobe PDF file" /></a></li>
				<li class="plugin-word"><a href="../../Other/plugins/index.html#doc"><img src="../../TemplatePackage/images/icon_word.gif" alt="Microsoft Word file" /></a></li>
				<li class="plugin-excel"><a href="../../Other/plugins/index.html#xls"><img src="../../TemplatePackage/images/icon_excel.gif" alt="Microsoft Excel file" /></a></li>
				<li class="plugin-ppt"><a href="../../Other/plugins/index.html#ppt"><img src="../../TemplatePackage/images/icon_ppt.gif" alt="Microsoft PowerPoint file" /></a></li>
				<li class="plugin-wmv"><a href="../../Other/plugins/index.html#wmv"><img src="../../TemplatePackage/images/icon_wmv.gif" alt="Audio/Video file" /></a></li>
				<li class="plugin-zip"><a href="../../Other/plugins/index.html#zip"><img src="../../TemplatePackage/images/icon_zip.gif" alt="Zip Archive file" /></a></li>
				<li class="plugin-real"><a href="../../Other/plugins/index.html#ram"><img src="../../TemplatePackage/images/icon_real.gif" alt="RealPlayer file" /></a></li>
				<li class="plugin-qt"><a href="../../Other/plugins/index.html#qt"><img src="../../TemplatePackage/images/icon_qt.gif" alt="Apple Quicktime file" /></a></li>
			</ul>
			<p><a href="../../Other/plugins/index.html"><span class="tp-label">How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?</span>&nbsp;<img src="../../TemplatePackage/images/btn_dblArrows.gif" alt="double arrows." /></a></p>
		</div>
			<div class="pageOptions-horizontal">
				<ul class="services">
					<li class="print"><a href="javascript:window.print();">Print</a></li>
<!-- InstanceBeginEditable name="local-options-horizontal" -->
				<!--<li class="pdf"><a href="">Download</a></li>-->
				 
				<!--<li class="rss"><a href="">Subscribe</a></li>-->
				<!-- InstanceEndEditable -->
				</ul>
			</div>
			<div id="datestamp"><!-- InstanceBeginEditable name="date-stamp" -->
            
            <div class="syndicate">  
    <div class="mSyndicate">  

			<ul>
				<li class="last-reviewed">Page last reviewed: <span> February 8, 2011</span></li>
				<li class="last-updated">Page last updated: <span>February 8, 2011</span></li>
				 <li class="content-source">Content source: <a href="../../index.html">Centers for Disease Control and Prevention</a><br /> <a href="../../ncezid.1.html">National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)</a><br /> <a href="../../ncezid/dhqp/index.html">Division of Healthcare Quality Promotion (DHQP)</a></li>

		</ul>
        </div>
        </div>
		<!-- InstanceEndEditable -->
			</div>
			
		</div>
		<div id="siteinfo">
	<div id="siteinfo-nav">
		<ul class="menu">
			<li><a href="../../index.html">Home</a></li>
			<li><a href="../../az/a.html">A-Z Index</a></li>
			<li><a href="../../Other/policies.html">Policies</a></li>
			<li><a href="../../Other/about_cdcgov.html">Using this Site</a></li>
			<li><a href="../../Other/link.html">Link to Us</a></li>
			<li class="last-child"><a href="../../contact.1.html">Contact CDC</a></li>
		</ul>
	</div>
	<div id="siteinfo-credits">
		<div id="siteinfo-logos"><a href="https://www.usa.gov//"><img id="logo_usagov" src="../../TemplatePackage/images/logo_usagov.gif" alt="USA.gov: The U.S. Government's Official Web Portal" width="188" height="55" border="0" /></a><a href="https://www.hhs.gov/"><img id="logo_dhhs" src="../../TemplatePackage/images/logo_dhhs.gif" alt="Department of Health and Human Services" width="61" height="55" border="0" /></a></div>
		<address>Centers for Disease Control and Prevention &nbsp; 1600 Clifton Road Atlanta, GA 30329-4027, USA<br />
		800-CDC-INFO (800-232-4636)	TTY: (888) 232-6348 - <a href="https://wwwn.cdc.gov/dcs/RequestForm.aspx">Contact CDC&ndash;INFO</a></address>
	</div>
</div>

<!--include virtual="/TemplatePackage/3.0/includes/interstitialModal.html" -->
		
		<div id="AZlist-container"><a name="az"></a>
	<span>A-Z Index</span>
	<ol class="AZlist">
		<li><a href="../../az/a.html">A</a></li>
		<li><a href="../../az/b.html">B</a></li>
		<li><a href="../../az/c.html">C</a></li>
		<li><a href="../../az/d.html">D</a></li>
		<li><a href="../../az/e.html">E</a></li>
		<li><a href="../../az/f.html">F</a></li>
		<li><a href="../../az/g.html">G</a></li>
		<li><a href="../../az/h.html">H</a></li>
		<li><a href="../../az/i.html">I</a></li>
		<li><a href="../../az/j.html">J</a></li>
		<li><a href="../../az/k.html">K</a></li>
		<li><a href="../../az/l.html">L</a></li>
		<li><a href="../../az/m.html">M</a></li>
		<li><a href="../../az/n.html">N</a></li>
		<li><a href="../../az/o.html">O</a></li>
		<li><a href="../../az/p.html">P</a></li>
		<li><a href="../../az/q.html">Q</a></li>
		<li><a href="../../az/r.html">R</a></li>
		<li><a href="../../az/s.html">S</a></li>
		<li><a href="../../az/t.html">T</a></li>
		<li><a href="../../az/u.html">U</a></li>
		<li><a href="../../az/v.html">V</a></li>
		<li><a href="../../az/w.html">W</a></li>
		<li><a href="../../az/x.html">X</a></li>
		<li><a href="../../az/y.html">Y</a></li>
		<li><a href="../../az/z.html">Z</a></li>
		<li><a href="../../az/0.html">#</a></li>
	</ol>
</div>

	<!-- /end #wrapper-inner --></div>
	
<!-- /end #wrapper --></div>

<!-- xxxxxxxxxxxxxxxxxx METRICS code begins here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->
<div id="metrics">

<!-- Begin Google DAP inclusion -->
<script type="text/javascript" id="_fed_an_ua_tag" src="../../JScript/metrics/google/Universal-Federated-Analytics-Min.js@agency=HHS&amp;subagency=CDC"></script>
<!-- End Google DAP inclusion -->

<!-- SiteCatalyst code version: H.21. -->
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/topic_levels.js"></script>
<script language="JavaScript" type="text/javascript" src="../../JScript/metrics/s_code_v21_cdcgov.js"></script>
<script language="JavaScript" type="text/javascript">

<!-- InstanceBeginEditable name="metrics" -->
s.pageName=document.title;
s.channel="HICPAC";

siteCatalyst.setLevel1("NCEZID"); 
siteCatalyst.setLevel2("DHQP"); 
siteCatalyst.setLevel3("Healthcare Infection Control Practices Advisory Committee"); 
<!-- InstanceEndEditable -->
s.prop2=window.location.href;
s.prop26=document.title;
s.prop30=document.title;
s.prop31=window.location.href;
s.prop46=window.location.href;
s.server=window.location.hostname;

// Update the level variables here.
updateVariables(s);

/************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/
var s_code=s.t();if(s_code)document.write(s_code);//--></script>
<script language="JavaScript" type="text/javascript"><!--
if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-');
//--></script><noscript><a href="http://www.omniture.com" title="Web Analytics"><img src="https://smtrics.cdc.gov/b/ss/cdcgov/1/H.21--NS/01/H.21--NS/0" height="1" width="1" border="0" alt="Web Analytics" /></a></noscript><!--/DO NOT REMOVE/-->
<!-- End SiteCatalyst code version: H.21. -->
<!-- Begin Template Package Custom Interactions -->
<script type="text/javascript" src="../../JScript/metrics/rd_custom_interactions.js"></script>
<!-- End Template Package Custom Interactions -->
<!-- Begin Template Package DigitalGov Search Support -->
<script type="text/javascript" src="../../JScript/rd_search.js"></script>
<!-- End Template Package DigitalGov Search Support -->
</div>
<!-- xxxxxxxxxxxxxxxxxx METRICS code ends here xxxxxxxxxxxxxxxxxxxxxxxxxxx-->



</body>
<!-- InstanceEnd --></html>